NCT05364541 is a NA clinical trial of MyoVista wavECG in Health Screening, sponsored by Heart Test Laboratories, Inc..

Who is sponsoring NCT05364541?

NCT05364541 is sponsored by Heart Test Laboratories, Inc..

What drugs are being tested in NCT05364541?

Interventions in NCT05364541: MyoVista wavECG.

What condition does NCT05364541 study?

NCT05364541 studies Health Screening.

Is NCT05364541 still recruiting?

NCT05364541 is currently status unknown. Last updated 21 September 2023.

Last reviewed 2023-09-21 · How we verify

NCT05364541

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MyoVista wavECG Clinical Evaluation: >=60 y/o Enrichment Population

Status unknown NA Last updated 21 September 2023

What this trial tests

NA trial testing MyoVista wavECG in Health Screening in 50 participants. Status unknown.

Timeline

1 June 2022

Primary endpoint
15 July 2023

30 November 2023

Quick facts

Lead sponsor	Heart Test Laboratories, Inc.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	50
Start date	1 June 2022
Primary completion	15 July 2023
Estimated completion	30 November 2023
Sites	1 location across United States

Drugs / interventions tested

MyoVista wavECG

Conditions studied

Health Screening — all drugs for Health Screening →

Sponsor

Heart Test Laboratories, Inc.

Who can join

60 and older, any sex, with Health Screening. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-center, interventional, single arm clinical study of the MyoVista wavECG for the detection of LV relaxation abnormalities. The study will be conducted at a single investigational site within the United States. Study subjects will predominately be screened from among those who have been enrolled in prior registry studies by the institution.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Health Screening

Currently open trials in the same condition.

NCT06910956 — Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT · NA · recruiting

Other Heart Test Laboratories, Inc. trials

Trials by the same sponsor.

NCT04804969 — MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05364541 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Heart Test Laboratories, Inc.
Last refreshed: 21 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05364541.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing